

See product citations (7)
QUICK LINKS
MDV3100 is an androgen receptor inhibitor and antagonizes induction of prostate-specific antigen (PSA) and transmembrane serine protease 2 (TMPRSS2) in combination with the synthetic androgen R1881 in parental LNCaP cells. It also prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. It reduces the efficiency of nuclear translocation of the androgen receptor, and then impairs its binding to DNA and the recruitment of coactivators. MDV3100 is able to induce tumor regression in mice models of prostate cancer.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MDV3100, 5 mg | sc-364354 | 5 mg | $245.00 | |||
MDV3100, 50 mg | sc-364354A | 50 mg | $1051.00 |